North America dominates the Hip And Knee Replacement Devices market, accounting for 40% of global revenue, driven by advanced healthcare infrastructure, high adoption rates of minimally invasive procedures, and a significant aging population. Europe follows at 30%, bolstered by mature reimbursement policies, cost-conscious healthcare systems, and a strong focus on innovation. Asia Pacific, at 15%, is the fastest-growing region, fueled by rising geriatric populations, improving healthcare access, and surging investments in orthopedic infrastructure. Latin America (10%) and the Middle East & Africa (5%) lag behind due to uneven healthcare access but show potential amid growing awareness and government-driven healthcare reforms.